Advertisement

Topics

Latest "irbesartan amlodipine irbesartan Hypertension" News Stories

06:27 EDT 24th August 2017 | BioPortfolio

Here are the most relevant search results for "irbesartan amlodipine irbesartan Hypertension" found in our extensive news archives from over 250 global news sources.

More Information about irbesartan amlodipine irbesartan Hypertension on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about irbesartan amlodipine irbesartan Hypertension for you to read. Along with our medical data and news we also list irbesartan amlodipine irbesartan Hypertension Clinical Trials, which are updated daily. BioPortfolio also has a large database of irbesartan amlodipine irbesartan Hypertension Companies for you to search.

Showing "irbesartan amlodipine irbesartan Hypertension" News Articles 1–25 of 967

Extremely Relevant

Global and Chinese Irbesartan Industry, 2017 Market Research Report [Report Updated: 21062017] Prices from USD $3000

The 'Global and Chinese Irbesartan Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Irbesartan industry with a focus on the Chinese market. The report provides key statistics on the market status of the Irbesartan manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry...


Global Irbesartan Market Research Report Forecast 20172022 [Report Updated: 05072017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Irbesartan Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It provides the Irbesartan industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an elaborate description o...

Human medicines European public assessment report (EPAR): Sabervel, irbesartan, Revision: 2, Withdrawn


FDA approves sale of Jubilant Pharma hypertension drug in US

India-based Jubilant Pharma has received FDA approval of its hypertension drug amlodipine and olmesartan medoxomil, the firm' -More- 

Unisia Amlodipine + Candesartan Drug Insights, 2017 [Report Updated: 10072017] Prices from USD $1000

DelveInsight's pharmaceuticals report, Unisia Amlodipine + Candesartan Drug Insights, 2017 highlights the Drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Unisia Amlodipine + Candesartan covering the historical global sales and also provides the Unisia Amlodipine + Candesartan sales esti...

Unisia Amlodipine + Candesartan API Insights, 2017 [Report Updated: 10072017] Prices from USD $500

DelveInsight's, Unisia Amlodipine + Candesartan API Insights, 2017 report provides product and API manufacturers details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to the Unisia Amlodipine + Candesartan. The report also highlights the patent details of Unisia Amlodipine + Candesartan. The report is built u...

Hypertension, diabetes generics from Aurobindo get FDA OK

Aurobindo Pharma's generic amlodipine and olmesartan medoxomil tablets, 5 mg/20 mg, 5 mg/40 mg, 10 mg/20 mg and 10 mg/40 mg,  -More- 

Relevant

Global and Chinese Amlodipine Naphthoquinone Industry, 2017 Market Research Report [Report Updated: 21062017] Prices from USD $3000

The 'Global and Chinese Amlodipine Naphthoquinone Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Amlodipine Naphthoquinone industry with a focus on the Chinese market. The report provides key statistics on the market status of the Amlodipine Naphthoquinone manufacturers and is a valuable source of guidance and direction for compani...

Long-term Candesartan Linked to Less New Diabetes vs Amlodipine

While candesartan and amlodipine lower blood pressure and cardiovascular event rates equally, candesartan is associated with significantly reduced rates of new-onset diabetes in 10-year follow-up data. Medscape Medical News

Early-Onset Hypertension Confers Greater Cardiovascular Risk than Late-Onset Hypertension (FREE)

Early-onset hypertension also is associated with excess hypertension risk in offspring.

Global Amlodipine Besylate Market Research Report Forecast 2017 to 2021 [Updated: 01052017] Prices from USD $2800

The Global Amlodipine Besylate Market Research Report Forecast 20172021 is a valuable source of insightful data for business strategists. It provides the Amlodipine Besylate industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an elaborate description of the value chain and its distributor analysis. Thi...

Aurobindo’s hypertension generic earns FDA approval

Brian BerkThe Division of Bioequivalence has determined Aurobindo's Aurobindo's Amlodipine and olmesartan medoxomil Tablets, 5 mg/20 mg, 5 mg/40 mg, 10 mg/20 mg, and 10 mg/40 mg to be bioequivalent and, therefore, therapeutically equivalent to the reference listed drug, Azor of Daiichi Sankyo and its Glipizide Extended-Release Tablets, 2.5 mg, 5 mg and 10 mg to be bioequivalent a...

Global Amlodipine Besylater Market Research Report Forecast 2017 to 2022 [Report Updated: 29062017] Prices from USD $2800

Delivery of the Report will take 23 working days once order is placed.The Global Amlodipine Besylater Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It provides the Amlodipine Besylater industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an el...

Lifestyle and Progression From HDP to Chronic Hypertension

Can the risk of chronic hypertension after gestational hypertension or pre-eclampsia be significantly reduced by adherence to a beneficial lifestyle? The BMJ (formerly known as the British Medical Journal)

Hypertension during pregnancy may affect women's long-term cardiovascular health

(Wiley) Women who experience hypertension during pregnancy face an increased risk of heart disease and hypertension later in life, according to a new study.

Screen for Endocrine Hypertension, Endocrine Society Says

The Endocrine Society has issued a new statement on endocrine hypertension, providing guidance on screening for at least 15 hormonal disorders that present with hypertension. Medscape Medical News

American Society of Hypertension to Offer Clinical Hypertension Review Course to Physicians March 2nd and 3rd, 2012

NEW YORK, Feb. 2, 2012 /PRNewswire/ -- The American Society of Hypertension (ASH) will once again offer the Clinical Hypertension Review Course to cardiologists, nephrologists and internists with an interest in the treatment and management of hypertension. The course will be offered on March 2nd and 3rd, 2012 in Atlanta, GA. The intensive two-day course is designed to be an immersion in e...

Hypertension: Hypertension in pregnancy: a risk factor for the whole family?

Hypertension in pregnancy is a known risk factor for increased cardiovascular risk for both the mother and her offspring. New findings suggest the offspring of normotensive pregnancies should also be considered at risk of high blood pressure if their mother has had hypertension in other pregnancies.

Dimerix hosts US key opinion leader meeting with NephCure Kidney International focused on development path of DMX-200 in kidney disease

MELBOURNE, Australia, 6th June 2017: Dimerix Limited (ASX: DXB), a clinical-stage biotechnology company discovering and developing new therapeutic treatments identified using its proprietary assay technology said it has hosted a half-day meeting on Saturday 3 June 2017 in Baltimore, Maryland United States, with representatives from the patient advocacy group NephCure Kidney International and lea...

Tackling hypertension in India

The World Health Organization has chosen hypertension as the public health threat it will focus on for the next year. The problem is particularly pressing in India, and Anita Jain, the BMJ's India editor, spoke to François Decaillet, Coordinator for Health Programs, WHO India, about what needs to be done to tackle hypertension in the country's...

Hypertension before the age of 55 increases risk of cardiovascular death

When someone gets diagnosed with hypertension, either early (before the age of 55) or later in life, can have important health ramifications.

Can Echo/Doppler Accurately Estimate LVEDP in Pulmonary Hypertension Patients?

In patients with pulmonary hypertension evaluated in a specialty clinic, echo/Doppler estimation of left ventricular end-diastolic pressure is not reliable for the determination of pre- vs. post-capillary pulmonary hypertension.

Heritability and risks associated with early onset hypertension: multigenerational, prospective analysis in the Framingham Heart Study

Objective To determine the role of early onset versus late onset hypertension as a risk factor for hypertension in offspring and cardiovascular death.Design Multigenerational, prospective cohort...

Hypertension: Role of γδ T cells in the development of hypertension

Vascular Dynamics to initiate resistant hypertension trial

Vascular Dynamics, Inc., (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, announces that the FDA has approved the company’s Investigational Device Exemption (IDE) application to initiate its pivotal trial for its MobiusHD System for the treatment of resistant hypertension. The CALM (Controlling and Lowering Blood Pressure with MobiusHD)...


Quick Search
Advertisement
 

News Quicklinks